You are absolutely right, the financing, for the forseeable future, will be in the form of dilution of the stock and the reason it will continue is because CYGX has no revenue. If they had revenue they could service debt bla bla bla bla....I'm just glad that management is able to periodically reward themselves, with additional stock, for the work the professionals in the lab are accomplishing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.